Recent advances in preclinical drug development in multiple sclerosis

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.8, Iss.7, 1998-07, pp. : 831-854

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Disease-Modifying Agents for Multiple Sclerosis: Recent Advances and Future Prospects

By Menge Til

Drugs, Vol. 68, Iss. 17, 2008-01 ,pp. : 2445-2468

Adis International

Access to resources Recommend Favorite

Metabonomics in preclinical drug development

By Robertson Donald G Reily Michael D Baker J David

Expert Opinion on Drug Metabolism and Toxicology, Vol. 1, Iss. 3, 2005-10 ,pp. : 363-376

Informa Healthcare

Access to resources Recommend Favorite

A Review of: "Preclinical Drug Development"

By Keep Marcus F.

Drug Development and Industrial Pharmacy, Vol. 33, Iss. 4, 2007-04 ,pp. : 493-493

Informa Healthcare

Access to resources Recommend Favorite

Recent Advances of Fluorescent Technologies for Drug Discovery and Development

Current Pharmaceutical Design, Vol. 15, Iss. 30, 2009-10 ,pp. : 3552-3570

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in Preclinical Studies and Potential Applications of Dendrimers as Drug Carriers in the Central Nervous System

Current Pharmaceutical Design, Vol. 23, Iss. 21, 2017-08 ,pp. : 3105-3119

Bentham Science Publishers

Access to resources Recommend Favorite